Congress to Drug Makers: Why Stock Buybacks Over Lowered Drug Prices?

House Democrats say big pharmaceutical companies channeled tax savings to repurchasing shares instead of making some medicines more affordable.

from WSJ.com: US Business https://ift.tt/2zL49Re
via IFTTT